Sterol metabolism and cancer

Biochem Pharmacol. 2022 Feb:196:114843. doi: 10.1016/j.bcp.2021.114843. Epub 2021 Nov 18.

Author

Affiliation

¹ Team "Cholesterol Metabolism and Therapeutic Innovations", Cancer Research Center of Toulouse (CRCT), UMR 1037 INSERM, UMR 5071 CNRS, Université de Toulouse III, Toulouse, France; Equipe labellisée par la Ligue Nationale Contre le Cancer, France; French Network for Nutrition And Cancer Research (NACRe Network), France. Electronic address: marc.poirot@inserm.fr.

PMID: 34801524
DOI: 10.1016/j.bcp.2021.114843

No abstract available

Publication types

Editorial

MeSH terms

Animals
Anticholesteremic Agents / pharmacology
Anticholesteremic Agents / therapeutic use
Humans
Lipid Metabolism / drug effects
Lipid Metabolism / physiology*
Neoplasms / drug therapy
Neoplasms / genetics
Neoplasms / metabolism*
Nuclear Receptor Subfamily 1, Group F, Member 3 / genetics
Nuclear Receptor Subfamily 1, Group F, Member 3 / metabolism
Sterols / antagonists & inhibitors
Sterols / metabolism*

Substances

Anticholesteremic Agents
Nuclear Receptor Subfamily 1, Group F, Member 3
Rorc protein, mouse
Sterols